Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
21.71
-0.50 (-2.25%)
At close: Mar 12, 2026, 4:00 PM EDT
21.51
-0.20 (-0.92%)
Pre-market: Mar 13, 2026, 6:00 AM EDT
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.09 billion as of March 13, 2026. Its market cap has decreased by -44.53% in one year.
Market Cap
2.09B
Enterprise Value
2.61B
1-Year Change
-44.53%
Ranking
Category
Stock Price
$21.71
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.09B, an increase of 76.09%. That is a compound annual growth rate of 4.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 2.15B | -3.29% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 2.22B |
| Day One Biopharmaceuticals | 2.20B |
| Mineralys Therapeutics | 2.14B |
| Galapagos NV | 2.14B |
| Syndax Pharmaceuticals | 2.13B |
| Zai Lab | 2.11B |
| Stoke Therapeutics | 2.09B |
| Veradermics | 2.02B |